With the rapid development of precision tumor treatment, the demand for standardized diagnosis and treatment has become increasingly urgent. After years of basic and clinical research, significant progress has been made in tumor diagnosis and treatment, especially targeted therapy and immunotherapy, which have become the mainstream methods of tumor treatment at present. To further improve the clinical diagnosis and treatment level of primary medical institutions in the field of tumors, new progress and trends are shared. Against this backdrop, the Chengdu High-tech Medical Association plans to hold the "Bispecific Antibody Innovation Forum" in Chengdu on May 7, 2025. The conference will focus on hot topics such as "Mechanism of Action of Bispecific Antibodies", "Progress in Bispecific Antibody Immunotherapy for Lung Cancer", and "Progress in Bispecific Antibody Immunotherapy for Cervical Cancer" for academic exchanges. Jointly explore the new progress in bispecific antibody therapy and share experiences.